Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:952 (10 November), doi:10.1136/bmj.39388.456065.1F
| The first 150 words of the full text of this article appear below. |
Health systems need to use resources to their maximum effect. This naturally leads them towards evidence based medicine, since those interventions that have been shown in well conducted (randomised) studies to be most effective should usually be prioritised over those where high quality evidence is lacking.
Problems arise where systems have to juggle alternative choices where the evidence is lacking or weak, or the benefits/harms trade off is marginal. The figures quoted by Garrow (previous letter) from BMJ Clinical Evidence are correct, but they provide an overly pessimistic picture of the state of evidence for orthodox medicine, since interventions in complementary and alternative medicine (CAM) and other non-orthodox treatments are included and are over-represented in the "unknown" category. Contrary to Garrow's implication, however, where multiple well conducted studies have shown no effect BMJ Clinical Evidence would categorise these interventions as "unlikely to be beneficial" rather than "unknown effectiveness." None the
David I Tovey, editorial director
BMJ Knowledge, BMJ Group, London WC1H 9JR
dtovey@bmjgroup.com
Read all Rapid Responses